Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | References | |
Homo sapiens | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | References | |
Homo sapiens | solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | sodium:dicarboxylate symporter | 0.0457 | 0.5 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 3 | 0.0457 | 0.5 | 0.5 |
Echinococcus granulosus | neutral amino acid transporter | 0.0457 | 0.5 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter excitatory amino acid transporter | 0.0457 | 0.5 | 0.5 |
Echinococcus granulosus | sodium:dicarboxylate symporter | 0.0457 | 0.5 | 0.5 |
Chlamydia trachomatis | glutamate symporter | 0.0457 | 0.5 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.0457 | 0.5 | 0.5 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.0457 | 0.5 | 0.5 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.0457 | 0.5 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.0457 | 0.5 | 0.5 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.0457 | 0.5 | 0.5 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.0457 | 0.5 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | Na+/H+-dicarboxylate symporter | 0.0457 | 0.5 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.0457 | 0.5 | 0.5 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.0457 | 0.5 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.0457 | 0.5 | 0.5 |
Onchocerca volvulus | Excitatory amino acid transporter homolog | 0.0457 | 0.5 | 0.5 |
Schistosoma mansoni | solute carrier family 1 (glial high affinity glutamate transporter | 0.0457 | 0.5 | 0.5 |
Echinococcus granulosus | neutral amino acid transporter A | 0.0457 | 0.5 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.0457 | 0.5 | 0.5 |
Echinococcus granulosus | excitatory amino acid transporter 3 | 0.0457 | 0.5 | 0.5 |
Loa Loa (eye worm) | excitatory amino acid transporter | 0.0457 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Probable C4-dicarboxylate-transport transmembrane protein DctA | 0.0457 | 0.5 | 0.5 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.0457 | 0.5 | 0.5 |
Echinococcus granulosus | neutral amino acid transporter A | 0.0457 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5.62 | Inhibition of [3H]-D-Asp uptake at human EAAT2 expressed in HEK293 cells measured after 3 mins by TopCount method | LITERATURE. | 27636002 |
IC50 (binding) | = 5.92 | Inhibition of [3H]-D-Asp uptake at human EAAT3 expressed in HEK293 cells measured after 3 mins by TopCount method | LITERATURE. | 27636002 |
IC50 (binding) | = 6.1 | Inhibition of [3H]-D-Asp uptake at human EAAT1 expressed in HEK293 cells measured after 3 mins by TopCount method | LITERATURE. | 27636002 |
IC50 (binding) | = 0.8 uM | Inhibition of [3H]-D-Asp uptake at human EAAT1 expressed in HEK293 cells measured after 3 mins by TopCount method | LITERATURE. | 27636002 |
IC50 (binding) | = 1.2 uM | Inhibition of [3H]-D-Asp uptake at human EAAT3 expressed in HEK293 cells measured after 3 mins by TopCount method | LITERATURE. | 27636002 |
IC50 (binding) | = 2.4 uM | Inhibition of [3H]-D-Asp uptake at human EAAT2 expressed in HEK293 cells measured after 3 mins by TopCount method | LITERATURE. | 27636002 |
Inhibition (binding) | Displacement of [3H]CGP39653 from NMDA receptor in SPRD rat brain synaptic membranes up to 100 uM after 60 mins by TopCount microplate scintillation counting method | LITERATURE. | 27636002 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.